Global /China /Healthcare /Medical Devices /603367

Cisen Pharmaceutical Co., Ltd.

603367

• SSE: 603367 • Delayed

15.55CNY -0.7%

2.30 USD

As of 18 June 2026, Cisen Pharmaceutical Co., Ltd. has a market cap of $1.05B USD, ranking #10487 globally and #2934 in China. It ranks #936 in the Healthcare sector, and #188 in the Medical Devices industry.

Global Rank

10487

Country Rank

2934

Sector Rank

936

Industry Rank

188

Key Stats

Market Cap

$1.05BUSD

7.09B CNY

Enterprise Value

$587.48MUSD

3.97B CNY

Revenue (TTM)

$499.37MUSD

3.37B CNY

EBITDA (TTM)

$65.69MUSD

443.91M CNY

Net Income (TTM)

$60.44MUSD

408.45M CNY

EBITDA Margin

13%

Profit Margin

12%

PE Ratio

17.4

PS Ratio

2.1

PB Ratio

1.1

EV/EBITDA

8.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Zhenxin Du open_in_new

Employees

3,114

Founded

1970

Website

cisen-pharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.7%	0.4%	-6.3%	-12%	-26%	-10%	15%	-3.5%	19%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603367 辰欣药业股份有限公司 Class A ISIN: CNE100002VG4 Shares Out.: Shares Outstanding: 452.754M¹ Shares Float: 194.354M² TV: TradingView: SSE: 603367 SA: Stock Analysis: SHA: 603367 YF: Yahoo Finance: 603367.SS GF: Google Finance: SHA: 603367 BA: Barron's: 603367 MS: Morningstar: XSHG: 603367	15.55 CNY	TV: TradingView: SSE: 603367 SA: Stock Analysis: SHA: 603367 YF: Yahoo Finance: 603367.SS GF: Google Finance: SHA: 603367 BA: Barron's: 603367 MS: Morningstar: XSHG: 603367

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Cisen Pharmaceutical Co., Ltd.

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products. The company’s chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, anesthetic and analgesic drugs, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; raw materials; and packaging products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Jining, the People's Republic of China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.14B 203.66B CNY 3K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.65B 92.23B CNY 1K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.63B 38.02B CNY 436%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.54B 37.43B CNY 428%	52.7	China
APT Medical Inc. SSE: 688617	$5.05B 34.14B CNY 382%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.57B 30.86B CNY 335%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 16K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 15K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 15K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 12K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 11K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 10K%	22.2	Ireland

chevron_leftBack